Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationCarmen Martı́nez, Jorge Gayoso, Carmen Canals et al.|Journal of Clinical Oncology|2017Cited by 159
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCLPeter Dreger, Mehdi Hamadani, Anna Sureda et al.|Blood Advances|2019Cited by 115
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)Anna Candoni, Francesca Bonifazi, Giovanni Grillo et al.|Transplantation and Cellular Therapy|2019Cited by 49
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTRGiancarlo Fatobene, Mary Eapen, Vanderson Rocha et al.|Journal of Clinical Oncology|2020Cited by 44
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for LymphomasAlberto Mussetti, Anna Sureda, Abraham S. Kanate et al.|Transplantation and Cellular Therapy|2022Cited by 22